Completed
Effect of Seminal Plasma Insemination on Pregnancy Rates After IVF-ET
What is being tested
seminal plasma insemination
+ seminal plasma insemination
Procedure
Who is being recruted
From 20 to 41 Years
+4 Eligibility Criteria
How is the trial designed
Treatment Study
Placebo-Controlled
Interventional
Study Start: January 2012
Summary
Principal SponsorAssaf-Harofeh Medical Center
Last updated: March 12, 2013
Sourced from a government-validated database.Claim as a partner
Study start date: January 1, 2012
Actual date on which the first participant was enrolled.Seminal plasma insemination into the vaginal vault of patients undergoing IVF-ET increases uterine receptivity.
Principal SponsorAssaf-Harofeh Medical Center
Last updated: March 12, 2013
Sourced from a government-validated database.Claim as a partner
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Design Details
200 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
These studies test new ways to treat a disease, condition, or health issue. The goal is to see if a new drug, therapy, or approach works better or has fewer side effects than existing options.
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Criteria
Female
Biological sex of participants that are eligible to enroll.From 20 to 41 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Criteria
1 inclusion criteria required to participate
patients undergoing oocyte pick up for IVF treatment
3 exclusion criteria prevent from participating
endometriosis
low responders
uterine malformations
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Treatment Groups
Study Objectives
2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
Experimentalseminal plasma insemination
Group II
Placeboculture medium insemination
Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Infertility and IVF Unit, Assaf harofeh Medical Center
Zrifin, IsraelOpen Infertility and IVF Unit, Assaf harofeh Medical Center in Google MapsCompletedOne Study Center